FindMyKOL
Clinical trialNCT03478735CompletedInterventional

Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block

NCT03478735 is an interventional trial sponsored by Mayo Clinic. As of 18 Nov 2026, it is completed. It studies Cervicogenic Headache, Migraine Without Aura and 1 more condition. The registry lists an enrollment of 32 participants at 1 site in 1 country. The registry lists a start date of 17 Jul 2017 and a primary completion date of 14 Jun 2021.

SponsorMayo Clinic →Enrollment32Cervicogenic HeadacheMigraine Without AuraOccipital Neuralgia
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03478735
FieldValue
Registry IDNCT03478735
StatusCompleted
Study typeInterventional trial
Lead sponsorMayo Clinic
Enrollment32
Registered sites1
Countries1
ConditionsCervicogenic Headache, Migraine Without Aura and Occipital Neuralgia
Start17 Jul 2017
Primary completion14 Jun 2021
Study completion14 Jun 2021
Last update posted15 Jun 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will compare the analgesic benefit of a traditional landmark-guided GON block with the ultrasound-guided approach over a four week period in patients with occipital neuralgia or cervicogenic headache.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States1 site
  • Mayo Clinic in Rochester

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 1 siteMN1WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03478735

Each answer restates registry values shown on this page.

What is NCT03478735?

NCT03478735 is an interventional trial sponsored by Mayo Clinic. It studies Cervicogenic Headache, Migraine Without Aura and 1 more condition.

Who leads NCT03478735?

The registry names Matthew J Pingree, MD (principal investigator, Mayo Clinic) as the overall official.

Where does NCT03478735 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT03478735 end?

The registry lists a primary completion date of 14 Jun 2021 and a study completion date of 14 Jun 2021. The sponsor last updated the record on 15 Jun 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.